Publications
Found 163 results
Filters: Author is S Muyldermans [Clear All Filters]
"Antibody technology in proteomics.",
Brief Funct Genomic Proteomic, vol. 7, issue 4, pp. 275-82, 2008 Jul.
"Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.",
J Mol Biol, vol. 377, issue 2, pp. 478-88, 2008 Mar 21.
"Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.",
Biochemistry, vol. 47, issue 42, pp. 11041-54, 2008 Oct 21.
"Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.",
J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
"Single-domain antibodies as building blocks for novel therapeutics.",
Curr Opin Pharmacol, vol. 8, issue 5, pp. 600-8, 2008 Oct.
"A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins.",
Mol Cell Proteomics, vol. 7, issue 2, pp. 282-9, 2008 Feb.
"VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.",
Mol Immunol, vol. 45, issue 14, pp. 3847-56, 2008 Aug.
"Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains.",
BMC Biotechnol, vol. 7, pp. 7, 2007.
"ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome.",
Nat Methods, vol. 4, issue 1, pp. 13-7, 2007 Jan.
"Antibody repertoire development in camelids.",
Dev Comp Immunol, vol. 30, issue 1-2, pp. 187-98, 2006.
"Cloning and characterization of the dromedary (Camelus dromedarius) neonatal Fc receptor (drFcRn).",
Dev Comp Immunol, vol. 30, issue 12, pp. 1203-15, 2006.
"[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].",
Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.",
Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
"Heavy-chain-only antibody expression and B-cell development in the mouse.",
Crit Rev Immunol, vol. 26, issue 5, pp. 377-90, 2006.
"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.",
Proc Natl Acad Sci U S A, vol. 103, issue 12, pp. 4586-91, 2006 Mar 21.
"A synthetic camel anti-lysozyme peptide antibody (peptibody) with flexible loop structure identified by high-resolution affinity mass spectrometry.",
Chemistry, vol. 12, issue 7, pp. 1915-23, 2006 Feb 20.
"Targeting and tracing antigens in live cells with fluorescent nanobodies.",
Nat Methods, vol. 3, issue 11, pp. 887-9, 2006 Nov.
"Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.",
J Mol Biol, vol. 350, issue 1, pp. 112-25, 2005 Jul 1.
"Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing.",
Anal Chem, vol. 77, issue 23, pp. 7547-55, 2005 Dec 1.
"Expression of a dromedary heavy chain-only antibody and B cell development in the mouse.",
J Immunol, vol. 175, issue 6, pp. 3769-79, 2005 Sep 15.
"Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.",
J Mol Biol, vol. 352, issue 3, pp. 597-607, 2005 Sep 23.
"Nanobodies as novel agents for cancer therapy.",
Expert Opin Biol Ther, vol. 5, issue 1, pp. 111-24, 2005 Jan.
"Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays.",
Biosens Bioelectron, vol. 21, issue 3, pp. 483-90, 2005 Sep 15.
"Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.",
J Mol Biol, vol. 346, issue 3, pp. 773-88, 2005 Feb 25.
"Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires.",
J Biol Chem, vol. 280, issue 14, pp. 14114-21, 2005 Apr 8.